These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10780247)

  • 1. SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated rats.
    Costa B; Vailati S; Colleoni M
    Behav Pharmacol; 1999 May; 10(3):327-31. PubMed ID: 10780247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
    Adams IB; Compton DR; Martin BR
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity.
    Pan X; Ikeda SR; Lewis DL
    Mol Pharmacol; 1998 Dec; 54(6):1064-72. PubMed ID: 9855635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain.
    Rinaldi-Carmona M; Pialot F; Congy C; Redon E; Barth F; Bachy A; Brelière JC; Soubrié P; Le Fur G
    Life Sci; 1996; 58(15):1239-47. PubMed ID: 8614277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis.
    Santucci V; Storme JJ; Soubrié P; Le Fur G
    Life Sci; 1996; 58(6):PL103-10. PubMed ID: 8569415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine.
    Masserano JM; Karoum F; Wyatt RJ
    Behav Pharmacol; 1999 Jul; 10(4):429-32. PubMed ID: 10780811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2.
    Darmani NA
    Eur J Pharmacol; 2001 Oct; 430(1):49-58. PubMed ID: 11698062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat.
    Gueudet C; Santucci V; Rinaldi-Carmona M; Soubrié P; Le Fur G
    Neuroreport; 1995 Jul; 6(10):1421-5. PubMed ID: 7488739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
    Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between the CB1 receptor agonist Delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited.
    Järbe TU; Andrzejewski ME; DiPatrizio NV
    Pharmacol Biochem Behav; 2002 Nov; 73(4):911-9. PubMed ID: 12213538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice.
    Richardson JD; Aanonsen L; Hargreaves KM
    Eur J Pharmacol; 1997 Jan; 319(2-3):R3-4. PubMed ID: 9042616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.
    Navarro M; Hernández E; Muñoz RM; del Arco I; Villanúa MA; Carrera MR; Rodríguez de Fonseca F
    Neuroreport; 1997 Jan; 8(2):491-6. PubMed ID: 9080435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ; Crim JL; Darmani NA
    Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship study.
    Bass CE; Griffin G; Grier M; Mahadevan A; Razdan RK; Martin BR
    Pharmacol Biochem Behav; 2002 Dec; 74(1):31-40. PubMed ID: 12376150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats.
    Lichtman AH; Martin BR
    Pharmacol Biochem Behav; 1997; 57(1-2):7-12. PubMed ID: 9164547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.
    Aceto MD; Scates SM; Lowe JA; Martin BR
    Eur J Pharmacol; 1995 Aug; 282(1-3):R1-2. PubMed ID: 7498260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.
    Terranova JP; Storme JJ; Lafon N; Péŕio A; Rinaldi-Carmona M; Le Fur G; Soubrié P
    Psychopharmacology (Berl); 1996 Jul; 126(2):165-72. PubMed ID: 8856836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SR141716A induces in rats a behavioral pattern opposite to that of CB1 receptor agonists.
    Costa B; Colleoni M
    Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1103-8. PubMed ID: 11189200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precipitated and spontaneous withdrawal in rats tolerant to anandamide.
    Costa B; Giagnoni G; Colleoni M
    Psychopharmacology (Berl); 2000 Apr; 149(2):121-8. PubMed ID: 10805606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice.
    Darmani NA; Pandya DK
    J Neural Transm (Vienna); 2000; 107(8-9):931-45. PubMed ID: 11041273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.